Distinct phenotype, longitudinal changes of numbers and cell-associated virus in blood dendritic cells in SIV-infected CD8-lymphocyte depleted macaques.
Loss of circulating CD123+ plasmacytoid dendritic cells (pDCs) during HIV infection is well established. However, changes of myeloid DCs (mDCs) are ambiguous since they are studied as a homogeneous CD11c+ population despite phenotypic and functional heterogeneity. Heterogeneity of CD11c+ mDCs in primates is poorly described in HIV and SIV infection. Using multiparametric flow cytometry, we monitored longitudinally cell number and cell-associated virus of CD123+ pDCs and non-overlapping subsets of CD1c+ and CD16+ mDCs in SIV-infected CD8-depleted rhesus macaques. The numbers of all three DC subsets were significantly decreased by 8 days post-infection. Whereas CD123+ pDCs were persistently depleted, numbers of CD1c+ and CD16+ mDCs rebounded. Numbers of CD1c+ mDCs significantly increased by 3 weeks post-infection while numbers of CD16+ mDCs remained closer to pre-infection levels. We found similar changes in the numbers of all three DC subsets in CD8 depleted animals as we found in animals that were SIV infected animals that were not CD8 lymphocyte depleted. CD16+ mDCs and CD123+ pDCs but not CD1c+ mDCs were significantly decreased terminally with AIDS. All DC subsets harbored SIV RNA as early as 8 days and then throughout infection. However, SIV DNA was only detected in CD123+ pDCs and only at 40 days post-infection consistent with SIV RNA, at least in mDCs, being surface-bound. Altogether our data demonstrate that SIV infection differently affects CD1c+ and CD16+ mDCs where CD16+ but not CD1c+ mDCs are depleted and might be differentially regulated in terminal AIDS. Finally, our data underline the importance of studying CD1c+ and CD16+ mDCs as discrete populations, and not as total CD11c+ mDCs.
Department of Biology, Boston College, Chestnut Hill, Massachusetts, United States of America.
Caroline
C
Soulas
Department of Biology, Boston College, Chestnut Hill, Massachusetts, United States of America.
Patrick J
PJ
Autissier
Department of Biology, Boston College, Chestnut Hill, Massachusetts, United States of America.
Tricia H
TH
Burdo
AIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory, Frederick, MD 21702, United States of America.
Michael
M
Piatak
AIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory, Frederick, MD 21702, United States of America.
Jeffrey D
JD
Lifson
Department of Biology, Boston College, Chestnut Hill, Massachusetts, United States of America.
Kenneth C
KC
Williams
D000818:Animals; D039521:CD11c Antigen / Q000235:genetics / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology* / Q000473:pathology / Q000821:virology; D002452:Cell Count; D003713:Dendritic Cells / Q000145:classification / Q000276:immunology* / Q000473:pathology / Q000821:virology; D005434:Flow Cytometry; D015870:Gene Expression; D016130:Immunophenotyping; D053650:Interleukin-3 Receptor alpha Subunit / Q000235:genetics / Q000276:immunology; D008212:Lymphocyte Depletion; D008253:Macaca mulatta; D022423:Myeloid Cells / Q000145:classification / Q000276:immunology* / Q000473:pathology / Q000821:virology; D010641:Phenotype; D012367:RNA, Viral / Q000097:blood / Q000235:genetics / Q000276:immunology*; D017452:Receptors, IgG / Q000235:genetics / Q000276:immunology; D016097:Simian Acquired Immunodeficiency Syndrome / Q000097:blood / Q000276:immunology* / Q000473:pathology / Q000821:virology; D015302:Simian Immunodeficiency Virus / Q000276:immunology*; D013997:Time Factors
D039521:CD11c Antigen; D053650:Interleukin-3 Receptor alpha Subunit; D012367:RNA, Viral; D017452:Receptors, IgG